coronavirus
Showing 4426 - 4436 of 4,436
SARS Survivor Evaluations
Withdrawn
- Coronavirus (SARS-CoV)
-
Beijing, Beijing, China
- +1 more
Apr 25, 2013
Coronavirus (SARS-CoV) Trial in Houston (Aluminum hydroxide, Placebo, SARS-CoV)
Withdrawn
- Coronavirus (SARS-CoV)
- Aluminum hydroxide
- +2 more
-
Houston, TexasBaylor College of Medicine - Molecular Virology and Microbiology
Nov 29, 2012
Severe Acute Respiratory Syndrome Trial in Lai Chi Kok (Alferon LDO)
Completed
- Severe Acute Respiratory Syndrome
- Alferon LDO
-
Lai Chi Kok, Kowloon, Hong KongPrincess Margaret Hospital
Apr 16, 2013
SARS Trial in Iowa City, Saint Louis, Cincinnati (drug, other, biological)
Withdrawn
- SARS
- Aluminum hydroxide adjuvant (Alhydrogel®)
- +2 more
-
Iowa City, Iowa
- +2 more
Feb 14, 2013
Severe Acute Respiratory Syndrome Trial in Taipei (blood sampling)
Withdrawn
- Severe Acute Respiratory Syndrome
- blood sampling
-
Taipei, Taiwan, ChinaLi-Chieh Wang, MD
Dec 6, 2012
Japanese Encephalitis Trial in Kathmandu, Dharan (Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)])
Completed
- Japanese Encephalitis
- Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
-
Kathmandu, Bagmati, Nepal
- +1 more
May 18, 2013
Host Genetic Susceptibility to Avian Influenza A/H5N1
Completed
- Influenza A Virus/H5N1 Subtype
-
Hanoi, VietnamOxford University Clinical Research Unit
Nov 3, 2010
Cytokines in Human Monocytes by SARS-CoV in Adults and Children
Unknown status
- Healthy
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 30, 2007
Clinical Study of SARS in Children
Completed
- Epidemiology
- (no location specified)
Oct 26, 2005
Cytokine/Chemokine in Severe Acute Respiratory Syndrome
Completed
- SARS
- (no location specified)
Sep 12, 2005